Subrata Paul escapes with warning, NADA says no ban

Image
Press Trust of India New Delhi
Last Updated : Jul 05 2017 | 7:28 PM IST
Veteran India goalkeeper Subrata Paul today earned a massive reprieve after the National Anti- Doping Agency (NADA) revoked his provisional suspension, letting him off with a warning with regards to violation of anti-doping rule earlier this year.
The NADA stated that Paul has been able to prove that his dope violation was "not intentional". The regulatory body has directed the All India Football Federation to take action against the national team doctor.
The dope sample of Paul was collected on March 18 during an out-of-competition test in Mumbai by NADA.
His sample tested positive in National Dope Testing Laboratory (NDTL) for the presence of prohibited substance - Terbutaline (Beta-2-Agonist) - as per the WADA prohibited list 2017.
"In this case, the anti-doping rule violation involves a specified substance and the athlete was able to prove that the dope violation was not intentional. Under article 10.5.1.1 of the NADA code wherein a provision for no significant fault or negligence is available, Subrata Paul has been reprimanded for anti doping rule violation although no period of ineligibility has been imposed upon him. His suspension stands revoked with immediate effect," the NADA release stated.
ADDP conducted hearings on May 31 and June 6.
The disciplinary panel had some strong words for the AIFF, which had been negligent in providing proper guidelines for its players.
"The Anti Doping Disciplinary Panel has also warned the All India Football Federation for negligence as it has failed to provide guidelines to be followed by team doctor appointed by them. It is a strict liability of the federation to take absolute precaution for prohibited substances in any form either in medicines or dietary/nutritional supplements."
The panel has suggested action against the Indian team doctor.
"The doctor during his appearance before the panel had admitted in writing that he failed to take due care in prescribing the medicine to the athlete which led to his ingestion of prohibited substance. The federation has been directed to take necessary action against the team doctor," the release stated.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 05 2017 | 7:28 PM IST

Next Story